BENTHAM PRESS RELEASE!

Four Bentham Science Journals indexed in The Emerging Sources Citation Index (ESCI)

The Emerging Sources Citation Index (ESCI), a new database within the Web of Science by Clarivate Analytics, has accepted to index four journals published by Bentham Science Publishers. The titles are:

The Emerging Sources Citation Index (ESCI) is a new index by Clarivate Analytics, extending the range of publications in Web of Science to include high-quality, peer-reviewed publications of regional importance and in emerging scientific fields. ESCI complements the highly selective indexes by providing earlier visibility for sources under evaluation as part of SCIE, SSCI, and AHCI’s rigorous journal selection process. Inclusion in ESCI provides greater discoverability which leads to increased citations.

OPEN ACCESS ARTICLE – The Neurological Sequelae of Neonatal Hyperbilirubinemia – Current Pediatric Reviews

Journal: Current Pediatric Reviews

Author(s): Jean-Baptiste Le Pichon, Sean M. Riordan, Jon Watchko, Steven M. Shapiro*

Abstract:

Background: Despite its lengthy history, the study of jaundice, hyperbilirubinemia and kernicterus suffers from a lack of clarity and consistency in the key terms used to describe both the clinical and pathophysiological nature of these conditions. For example, the term Bilirubin-induced Neurological Dysfunction (BIND) has been used to refer to all neurological sequelae caused by exposure to high levels of bilirubin, to only mild neurological sequelae, or to scoring systems that quantitate the progressive stages of Acute Bilirubin Encephalopathy (ABE).

Objective: We seek to clarify and simplify terminology by introducing, defining, and proposing new terms and diagnostic criteria for kernicterus.

Methods: We propose a systematic nomenclature based on pathophysiological and clinical criteria, presenting a logical argument for each term. Acknowledging observations that kernicterus is symptomatically broad and diverse, we propose the use of the overarching term Kernicterus Spectrum Disorders (KSDs) to encompass all the neurological sequelae of bilirubin neurotoxicity including Acute Bilirubin Neurotoxicity (ABE). We further suggest subclassification of KSDs based on the principal disabling features of kernicterus (motor, auditory). Finally, we suggest the term subtle KSD to designate a child with a history of significant bilirubin neurotoxicity with mild or subtle developmental delays.

Results and Conclusion: We conclude with a brief description of the limited treatments currently available for KSD, thereby underscoring the importance of further research. We believe that adopting a systematic nomenclature for the spectrum of clinical consequences of hyperbilirubinemia will help unify the field and promote more effective research in both prevention and treatment of KSDs.

Read more here: http://www.eurekaselect.com/154919

 

TESTIMONIAL BY M ‘HAMED BENTOURKIA!

M`hamed Bentourkia

Contributed Article: “Insights In Developmental Coordination Disorder

EDITOR’S CHOICE – The Impact of Cancer and its Treatment on the Growth and Development of the Pediatric Patient – Current Pediatric Reviews

Journal: Current Pediatric Reviews

Author(s): Sarah Brand*, Joanne Wolfe, Chase Samsel

Graphical Abstract:

 

Abstract:

Background: Cancer treatment can have profound effects on the growth and development of pediatric patients. Different models of psychosocial development and behavioral treatment approaches aid children receiving medical treatment. Providing education, anticipatory guidance, and individualized support to child and their families is a psychosocial standard.

Objective: Clarify the different models of psychosocial development and applicable psychosocial interventions to better prepare and tailor cancer treatment to pediatric patients.

Methods: Authors reviewed existing evidenced-based literature in oncology, psychology, developmental, and psychiatric while drawing on case examples and expert knowledge to illustrate the impact of cancer treatment on pediatric patients, analyze developmentally individualized needs, and describe facilitative interventions.
Result: Pediatric patients of all ages cope and adjust better to all phases of treatment when their care is delivered in a developmentally-informed and psychosocially thoughtful way.
Conclusion: Providers can comprehensively prepare their patients and families for treatment better by utilizing a psychosocially- and developmentally-informed framework while meeting individualized unique needs of patients. An integrated multidisciplinary psychosocial support team is facilitative in anticipating and meeting the needs of pediatric cancer patients and has recently become a psychosocial standard of care.
To access the article, please visit: http://www.eurekaselect.com/147393

 

Editor’s Choice – The Impact of Cancer and its Treatment on the Growth and Development of the Pediatric Patient – Current Pediatric Reviews

Journal: Current Pediatric Reviews

Author(s): Sarah Brand, Joanne Wolfe, Chase Samsel.

Graphical Abstract:

 

Abstract:

Background: Cancer treatment can have profound effects on the growth and development of pediatric patients. Different models of psychosocial development and behavioral treatment approaches aid children receiving medical treatment. Providing education, anticipatory guidance, and individualized support to child and their families is a psychosocial standard.

Objective: Clarify the different models of psychosocial development and applicable psychosocial interventions to better prepare and tailor cancer treatment to pediatric patients.

Methods: Authors reviewed existing evidenced-based literature in oncology, psychology, developmental, and psychiatric while drawing on case examples and expert knowledge to illustrate the impact of cancer treatment on pediatric patients, analyze developmentally individualized needs, and describe facilitative interventions.
Result: Pediatric patients of all ages cope and adjust better to all phases of treatment when their care is delivered in a developmentally-informed and psychosocially thoughtful way.
Conclusion: Providers can comprehensively prepare their patients and families for treatment better by utilizing a psychosocially- and developmentally-informed framework while meeting individualized unique needs of patients. An integrated multidisciplinary psychosocial support team is facilitative in anticipating and meeting the needs of pediatric cancer patients and has recently become a psychosocial standard of care.

Most Accessed Article – Newborn Bilirubin Screening for Preventing Severe Hyperbilirubinemia and Bilirubin Encephalopathy – Current Pediatric Reviews

Journal: Current Pediatric Reviews

Author(s): Kalpana Bhardwaj, Tiffany Locke, Anne Biringer, Allyson Booth, Elizabeth K. Darling, Shelley Dougan, Jane Harrison, Stephen Hill, Ana Johnson, Susan Makin, Beth Potter, Thierry Lacaze-Masmonteil, Julian Little.

Graphical Abstract:

 

Abstract:

According to the 2004 American Academy of Pediatrics guideline on the management of hyperbilirubinemia, every newborn should be assessed for the risk of developing severe hyperbilirubinemia with the help of predischarge total serum bilirubin or transcutaneous bilirubin measurements and/or assessments of clinical risk factors. The aim of this rapid review is 1) to review the evidence for 1) predicting and preventing severe hyperbilirubinemia and bilirubin encephalopathy, 2) determining the efficacy of home/community treatments (home phototherapy) in the prevention of severe hyperbilirubinemia, and 3) non-invasive/transcutaneous methods for estimating serum bilirubin level. Methods: In this rapid review, studies were identified through the Medline database. The main outcomes of interest were severe hyperbilirubinemia and encephalopathy. A subset of articles was double screened and all articles were critically appraised using the SIGN and AMSTAR checklists. This review investigated if systems approach is likely to reduce the occurrence of severe hyperbilirubinemia. Results: Fifty-two studies met the inclusion criteria. Included studies assessed the association between bilirubin measurement early in neonatal life and the subsequent development of severe hyperbilirubinemia and chronic bilirubin encephalopathy/kernicterus. It was observed that, highest priority should be given to (i) universal bilirubin screening programs; (ii) implementation of community and midwife practice; (iii) outreach to communities for education of prospective parents; and (iv) development of clinical pathways to monitor, evaluate and track infants with severe hyperbilirubinemia. Conclusions: We found substantial observational evidence that severe hyperbilirubinemia can be accurately predicted and prevented through universal bilirubin screening. So far, there is no evidence of any harm.

To access the article, please visit: http://www.eurekaselect.com/149128

Highlighted Article – Insights in Developmental Coordination Disorder Marie – Current Pediatric Reviews

CPR-Articles_13-4-M`hamed Bentourkia

To access this article, please visit: http://www.eurekaselect.com/154487

Article by Disease – “Vitiligo in Children: A Birds Eye View”

Article by Disease on “Endocrine Diseases

Abstract:

Vitiligo in children is a distinct subset of vitiligo and differs from adult vitiligo. Characteristic features include family history of autoimmune or endocrine disease, higher incidence of segmental vitiligo, development of early or premature graying, increased incidence of autoantibodies and poor response to topical PUVA. The exact prevalence of vitiligo in children varies between 0.1-4% of the world population and seems to be higher in India than in other countries and it occurs more frequently in females. Around 12% to 35% of pediatric vitiligo patients have family members with the disease. The most common type of vitiligo in pediatric patients is vitiligo vulgaris, representing 78% of cases. The most commonly associated autoimmune disease is thyroiditis. Phototherapy and topical corticosteroids are the most commonly used treatments for adult vitiligo but are less useful in the pediatric population.

Read more: http://www.eurekaselect.com/node/138295/article

World Autism Awareness Day!

world--autism-day-bentham-science

World Autism Awareness Day observed on the 2nd of April, aims to increase awareness about people, especially children, with autism. Autism is a complex developmental disability; signs typically appear during early childhood and affect a person’s ability to communicate, and interact with others. There is no known single cause of autism, but increased awareness and early diagnosis/intervention and access to appropriate services/supports lead to significantly improved outcomes.

Bentham Science publishes research papers that present new studies related to this particular disease. Find the latest studies in the following journals:

Current Pediatric Reviews

CNS & Neurological Disorders – Drug Targets

World Down Syndrome Day 2017!

Down-Syndrome-Awareness-Day-bentham-science

World Down Syndrome Day (WDSD) is meant to spread global awareness of Down Syndrome which is caused by triplication (trisomy) of the 21st chromosome. Down syndrome is a rare chromosomal mutation that has has a significant impact on the affected person as well as the people around them. Being a genetic disorder, Down syndrome is observed in populations regardless of racial, gender and socio-economic lines.

Bentham Science journals publish papers that present research on this particular disease. Here are some articles covering Down Syndrome:

To view more articles, please visit: Current Pediatric Reviews